Mettler-Toledo International Inc. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Mettler-Toledo International Inc. (MTD) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $16.58 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-07.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2020-02-07
- Mettler-Toledo International Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-12-31 was $514.00K, a 95.53% decline year-over-year.
- Mettler-Toledo International Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-09-30 was $6.01M, a 4195.71% increase year-over-year.
- Mettler-Toledo International Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-06-30 was $5.35M, a 538.83% increase year-over-year.
- Mettler-Toledo International Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-03-31 was $5.80M, a 1216.33% increase year-over-year.
- Mettler-Toledo International Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2017 was $16.58M, a 6.21% decline from fiscal 2016.
- Mettler-Toledo International Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $17.68M, a 36.75% increase from fiscal 2015.
- Mettler-Toledo International Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $12.93M, a 263.48% increase from fiscal 2014.
- Mettler-Toledo International Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $3.56M, a 86.62% increase from fiscal 2013.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $16.58M 10-K · filed 2020-02-07 | $1.54M 10-Q · filed 2018-07-27 | |||
| 2016-12-31 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-08 | $6.53M derived: sum of 2 quarters · filed 2019-02-08 | $11.88M derived: sum of 3 quarters · filed 2019-02-08 | $17.68M 10-K · filed 2019-02-08 | |
| 2016-09-30 | $6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $11.36M derived: sum of 2 quarters · filed 2016-11-04 | $17.17M 10-Q · filed 2016-11-04 | $28.68M derived: sum of 4 quarters · filed 2018-02-09 | |
| 2016-06-30 | $5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $11.15M 10-Q · filed 2016-07-29 | $22.66M derived: sum of 3 quarters · filed 2018-02-09 | $22.80M derived: sum of 4 quarters · filed 2018-02-09 | |
| 2016-03-31 | $5.80M 10-Q · filed 2016-05-06 | $17.32M derived: sum of 2 quarters · filed 2018-02-09 | $17.46M derived: sum of 3 quarters · filed 2018-02-09 | $18.29M derived: sum of 4 quarters · filed 2018-02-09 | |
| 2015-12-31 | $11.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-09 | $11.65M derived: sum of 2 quarters · filed 2018-02-09 | $12.49M derived: sum of 3 quarters · filed 2018-02-09 | $12.93M 10-K · filed 2018-02-09 | |
| 2015-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $977.00K derived: sum of 2 quarters · filed 2015-11-06 | $1.42M 10-Q · filed 2015-11-06 | -$5.48M derived: sum of 4 quarters · filed 2017-02-02 | |
| 2015-06-30 | $837.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $1.28M 10-Q · filed 2015-07-31 | -$5.62M derived: sum of 3 quarters · filed 2017-02-02 | -$4.73M derived: sum of 4 quarters · filed 2017-02-02 | |
| 2015-03-31 | $441.00K 10-Q · filed 2015-05-08 | -$6.46M derived: sum of 2 quarters · filed 2017-02-02 | -$5.57M derived: sum of 3 quarters · filed 2017-02-02 | -$497.00K derived: sum of 4 quarters · filed 2017-02-02 | |
| 2014-12-31 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$6.01M derived: sum of 2 quarters · filed 2017-02-02 | -$938.00K derived: sum of 3 quarters · filed 2017-02-02 | $3.56M 10-K · filed 2017-02-02 | |
| 2014-09-30 | $890.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $5.96M derived: sum of 2 quarters · filed 2014-11-07 | $10.46M 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $9.57M 10-Q · filed 2014-07-25 | |||
| 2014-03-31 | $4.50M 10-Q · filed 2014-05-09 | ||||
| 2013-12-31 | $1.91M 10-K · filed 2016-02-04 | ||||
| 2012-12-31 | $8.82M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $9.02M derived: sum of 2 quarters · filed 2015-02-06 | $9.02M derived: sum of 3 quarters · filed 2015-02-06 | $9.32M 10-K · filed 2015-02-06 | |
| 2012-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $204.00K derived: sum of 2 quarters · filed 2012-11-02 | $502.00K 10-Q · filed 2012-11-02 | -$122.00K derived: sum of 4 quarters · filed 2014-02-07 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $298.00K 10-Q · filed 2012-07-27 | -$326.00K derived: sum of 3 quarters · filed 2014-02-07 | $1.41M derived: sum of 4 quarters · filed 2014-02-07 | |
| 2012-03-31 | $298.00K 10-Q · filed 2012-05-04 | -$326.00K derived: sum of 2 quarters · filed 2014-02-07 | $1.41M derived: sum of 3 quarters · filed 2014-02-07 | $4.46M derived: sum of 4 quarters · filed 2014-02-07 | |
| 2011-12-31 | -$624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $1.11M derived: sum of 2 quarters · filed 2014-02-07 | $4.16M derived: sum of 3 quarters · filed 2014-02-07 | $6.74M 10-K · filed 2014-02-07 | |
| 2011-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $4.78M derived: sum of 2 quarters · filed 2011-11-04 | $7.36M 10-Q · filed 2011-11-04 | $13.76M derived: sum of 4 quarters · filed 2013-02-08 | |
| 2011-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $5.63M 10-Q · filed 2011-08-01 | $12.03M derived: sum of 3 quarters · filed 2013-02-08 | $12.87M derived: sum of 4 quarters · filed 2013-02-08 | |
| 2011-03-31 | $2.58M 10-Q · filed 2011-05-05 | $8.98M derived: sum of 2 quarters · filed 2013-02-08 | $9.82M derived: sum of 3 quarters · filed 2013-02-08 | ||
| 2010-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $7.24M derived: sum of 2 quarters · filed 2013-02-08 | $10.78M 10-K · filed 2013-02-08 | ||
| 2010-09-30 | $840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $4.37M 10-Q · filed 2010-11-05 | |||
| 2010-06-30 | $3.53M 10-Q · filed 2010-07-23 | ||||
| 2009-12-31 | $2.90M 10-K · filed 2012-02-13 | ||||
| 2008-12-31 | $2.70M 10-K · filed 2011-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |